
Good morning. The abrupt resignation of a board member is a memorable occasion for a CEO—and even more so if all of the independent directors on the board quit at the same time. That actually happened last month to Anne Wojcicki, the CEO and cofounder of 23andMe, a genetic testing company. But on Tuesday, the company announced three new independent directors, and all are former finance chiefs.
At the genetic-testing company, there was some turmoil between Wojcicki, who wanted to buy the public company and take it private, and the former seven independent directors.